AlternativeMed
Ancient Wisdom Natural Remedies Modern Wellness
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases
Quick picks: Abetalipoproteinemia Abortion, Habitual Agenesis Acanthamoeba Keratitis Acanthosis Nigricans Achondrogenesis Achondroplasia Acne Vulgaris Acne Keloid Apert Syndrome
🏥 Disease / Health Topic

Non-Alcoholic Fatty Liver Disease

Open on HERB 2.0 ↗
17
Clinical Trials
40
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT05637866
SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic Outcomes
Active_Not_Recruiting
NCT04049396
Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD)
Completed
NCT03864783
The Effect of Curcumin on Liver Fat Content in Obese Subjects
Completed
📊 Sample Meta-Analyses
CRD42021232065
Sodium intake in relation with non-alcoholic fatty liver: A systematic review and meta-analysis of observational studies
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disorder a
CRD42017081750
Green tea as a safe alternative approach for non-alcoholic fatty liver treatment: a systematic review and meta-analysis
Patients who suffer from Non-alcoholic fatty liver disease (NAFLD).
CRD42022314590
The effects of purslane (Portulaca oleracea) on fasting blood sugar, liver enzymes, and dyslipidemia: A systematic review and meta-analysis of randomized clinical trials
We will investigate the effects of purslane on adult patients with dyslipidemia,
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Non-Alcoholic Fatty Liver Disease
🏥 Names
Disease Name
Non-Alcoholic Fatty Liver Disease
Alias Names
Fatty Liver Disease; Nonalcoholic Steatohepatitis; Non-Alcoholic Fatty Liver Disease
Topic Type
syndrome
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Disease or Syndrome
MeSH Class
Digestive System Diseases
DO Class
genetic disease; disease of metabolism
🔗 External References
HERB DB
HBDIS008864 ↗
MeSH
D065626 ↗
Disease Ontology
9452
DisGeNET
C0400966
🔍 Raw view — every non-empty column on this row (26 fields)
name
Non-Alcoholic Fatty Liver Disease
alias name
Fatty Liver Disease; Nonalcoholic Steatohepatitis; Non-Alcoholic Fatty Liver Disease
topic type
syndrome
disgenet disease type
disease
umls disease type
Disease or Syndrome
mesh disease class
Digestive System Diseases
do disease class
genetic disease; disease of metabolism
umls disease type id
T047
mesh disease class id
C06
do disease class id
DOID:0014667; DOID:630
herb disease id
HBDIS008864
disgenet id
C0400966
mesh id
D065626
do id
9452

🌿 Related Herbs

1 · shared evidence
Soybean

⚗️ Related Ingredients

9 · shared evidence
Berberime
Choline
Curcumin
Delta-d
Ornithine
Silymarin
Sulforathane
Ursodeoxycholic acid
Vitamin e

📋 Clinical Trials

12 · subject of clinical study
NCT05637866 SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic Outcomes
→ Cardiovascular Diseases|Lipid Disorder|Metabolic D
NCT04049396 Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD)
→ Non-Alcoholic Fatty Liver Disease
NCT03864783 The Effect of Curcumin on Liver Fat Content in Obese Subjects
→ Non-Alcoholic Fatty Liver Disease|Insulin Resistan
NCT00389376 Phase I Trial of Silymarin for Chronic Liver Diseases
→ Hepatitis C|Non-Alcoholic Fatty Liver Disease
NCT03749070 Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease - The S
→ Non-Alcoholic Fatty Liver Disease
NCT04364360 Sulforaphane Supplementation Study
→ Non-Alcoholic Fatty Liver Disease|Obesity|Metaboli
NCT01548079 Ursodeoxycholic Acid in Bariatric Surgery
→ Non-alcoholic Fatty Liver Disease|Morbid Obesity
NCT04198805 Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Pa
→ Non-Alcoholic Fatty Liver Disease|Non-Alcoholic Fa
NCT05042245 The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Sil
→ Non-alcoholic Fatty Liver Disease
NCT05042245 The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Sil
→ Non-alcoholic Fatty Liver Disease
NCT04315350 The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insuli
→ Insulin Resistance|Non-Alcoholic Fatty Liver Disea
NCT02006498 Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
→ Non-alcoholic Fatty Liver Disease

📊 Meta-Analyses

12 · systematic review
CRD42021232065 Sodium intake in relation with non-alcoholic fatty liver: A systematic review an
→ Non-alcoholic fatty liver disease (NAFLD) is the m
CRD42017081750 Green tea as a safe alternative approach for non-alcoholic fatty liver treatment
→ Patients who suffer from Non-alcoholic fatty liver
CRD42022314590 The effects of purslane (Portulaca oleracea) on fasting blood sugar, liver enzym
→ We will investigate the effects of purslane on adu
CRD42020212501 Effects of alpha-lipoic acid supplementation on non-alcoholic fatty liver diseas
→ Non-alcoholic fatty liver diseases (NAFLD)
CRD42020184592 efficiency and safety of berberine therapy in patients with non-alcoholic fatty
→ Efficacy of berberine against non-alcoholic fatty
CRD42021277602 Therapeutic effects and mechanisms of action of berberine on in Non-alcoholic fa
→ Non-alcoholic fatty liver disease (NAFLD), one of
CRD42018111638 Does turmeric and/or curcumin supplementation reduce BMI and/or weight in non-al
→ Turmeric or curcumin supplementation in patients w
CRD42021247600 The effects of curcumin supplementation on metabolic biomarkers and body mass in
→ Non-alcoholic fatty liver disease (NAFLD) is the m
CRD42022336529 Does curcumin supplementation improve nonalcoholic fatty liver disease? A system
→ Non-alcoholic fatty liver disease(NAFLD)
CRD42018110437 Effect of oleoylethanolamide on metabolic variables in non-alcoholic fatty liver
→ Non-alcoholic fatty liver disease (NAFLD) is the m
CRD42022322440 Therapeutic effects and mechanisms of action of genistein on in Non-alcoholic fa
→ Non-alcoholic fatty liver disease (NAFLD), one of
CRD42022354148 The association between the consumption of sugar-sweetened beverages (SSB) or ar
→ We explore multiple health-related outcomes: metab
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
  • Ingredient ↔ Target: empty — needs HERB_ingredient_target import
  • Target ↔ Disease: empty — needs HERB_target_disease import
  • Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables